Artificial Intelligence in Diagnosing Depression Through Behavioural Cues: A Diagnostic Accuracy Systematic Review and Meta-Analysis.

J Clin NursFeb 24, 2025 (epub)
Clinical ResearchPsychiatry

Yee Shyan Goh, Qi Rui See, Nopporn Vongsirimas et al.

✦ AI-curated · Sources linked

In 30 seconds

This diagnostic accuracy systematic review and meta-analysis assessed AI methods for detecting depression from behavioural cues in adults in healthcare and community settings. It included 30 studies; 20 reported that AI models had potential to detect depression. Across modalities, speech and facial expression showed better sensitivity, while text and movement showed better specificity. Heterogeneity was initially high and was lower within modality subgroups. The review considered speech, text, movement and facial expression, but the abstract does not report pooled accuracy estimates or numerical comparisons between modalities.

Key findings

  • Of 30 included studies, 20 indicated potential for AI models to detect depression.
  • Speech and facial expression showed better sensitivity for identifying people with depression.
  • Text and movement showed better specificity for ruling out non-depressed individuals.
  • Heterogeneity was initially high, with less heterogeneity within modality subgroups.

Why it matters

Depressive symptoms can be challenging to detect in general healthcare and community settings. The findings suggest that behavioural cues analysed by AI may offer a basis for objective screening, with different modalities showing strengths in sensitivity or specificity. This could inform development and evaluation of screening approaches, but the review does not establish that such systems improve diagnosis or patient outcomes.

What to keep in mind

The abstract reports high initial heterogeneity and provides no pooled accuracy estimates or numerical results. The evidence is based on included studies rather than a reported evaluation of an AI system in clinical practice.

Source

Published in J Clin Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.